Rankings
▼
Calendar
INVA Q3 2020 Earnings — Innoviva, Inc. Revenue & Financial Results | Market Cap Arena
INVA
Innoviva, Inc.
$1B
Q3 2020 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$89M
+34.9% YoY
Gross Profit
$89M
100.0% margin
Operating Income
$84M
95.2% margin
Net Income
$28M
31.8% margin
EPS (Diluted)
$0.26
QoQ Revenue Growth
+12.3%
Cash Flow
Operating Cash Flow
$75M
Free Cash Flow
$75M
Stock-Based Comp.
$441,000
Balance Sheet
Total Assets
$922M
Total Liabilities
$387M
Stockholders' Equity
$486M
Cash & Equivalents
$479M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$89M
$66M
+34.9%
Gross Profit
$89M
$66M
+34.9%
Operating Income
$84M
$61M
+38.9%
Net Income
$28M
$40M
-29.1%
← FY 2020
All Quarters
Q4 2020 →